Article
Clusterin: a marker and mediator of chemoresistance in colorectal cancer
6 Feb 2024
Abstract excerpt
Abstract Intra-tumoural heterogeneity and cancer cell plasticity in colorectal cancer (CRC) have been key challenges to effective treatment for patients. It has been suggested that a subpopulation of LGR5-expressing cancer stem cells (CSCs) is responsible for driving tumour relapse and therapy resistance in CRC. However, studies have revealed that the LGR5+ve CSC population is highly sensitive to chemotherapy. It...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
